Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system

Bone Marrow Transplantation

Volumn 21, Issue 12, 1998, Pages 1253-1262

  Rowley, S D ^a   Loken, M ^b   Radich, J ^a   Kunkle, L A ^c   Mills, B J ^c   Gooley, T ^a   Holmberg, L ^a   McSweeney, P ^a   Beach, K ^a   MacLeod, B ^a   Appelbaum, F ^a   Bensinger, W I ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b HEMATOLOGICS INC   (United States)

^c BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Autologous stem cell transplantation; CD34; Peripheral blood stem cells; Purging

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APHERESIS; ARTICLE; BONE MARROW PURGING; CELL COUNT; CELL ISOLATION; CELL SEPARATION; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0031875711     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701257     Document Type: Article

References (29)

1. Civin CI, Strauss LC, Brovall C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133: 157-165.
2. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996; 87: 1-13.
3. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158-3163.
4. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-1722.
5. Shpall EJ, Jones RB, Bearman SI et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J clin Oncol 1994; 12: 28-36.
6. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994; 84: 1421-1426.
7. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 1995; 85: 1657-1654.
8. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
9. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating Factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
10. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996; 88: 4132-4138.
11. + cells to remove circulating tumor cells. Blood 1996; 87: 1625-1634.
12. + blood cells. Blood 1996; 87: 4903-4909.
13. Hardwick AR, Kulcinski D, Mansour V et al. Design of large scale separation sysems for positive and negative selection of cells using superparamagnetic microspheres. J Hematother 1992; 1: 379-386.
14. Hardwick AR, Law P, Kulcinshi D et al. Development of a large scale immunomagnetic separation system for harvesting CD34 cells from bone marrow. Prog Clin Biol Res 1992; 377: 583-589.
15. Demirer T, Buckner CD, Storer B et al. Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor. J Clin Oncol 1997; 15: 684-690.
16. Bensinger WI, Schiffman KS, Holmberg L et al. High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Bone Marrow Transplant 1997; 19: 1183-1189.
17. Blume KG, Forman SJ. High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies. Semin Oncol 1992; 19 (Suppl. 13): 63-66.
18. Press OW, Eary JF, Appelbaum FR et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. New Engl J Med 1993; 329: 1219-1224.
19. Rowley SD, Bensinger WI, Gooley TA, Buckner CD. The effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994; 83: 2731-2736.
20. Stelzer GT, Shults KE, Wormsley SB, Loken MR. Detection of occult lymphoma cells in bone marrow aspirates by multidimensional flow cytometry. Prog Clin Biol Res 1992; 337: 629-634.
21. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci 1993; 677: 265-280.
22. McSweeney PA, Wells DA, Shults KE et al. Tumor-specific aneuploidy not detected in CD19-positive B-lymphoid cells from myeloma patients in a multi-dimensional flow cytometric analysis. Blood 1996; 88: 622-631.
23. Lambrechts AC, Hupkes PE, Dorssers LCJ, van't Veer MB. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood 1993; 82: 2510-2516.
24. Kwok S, Higushi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
25. Radich JP, Kopecky K, Willman CL et al. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and significance. Blood 1990; 76: 801-807.
26. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
27. Einsele H, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus dis ease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995; 86: 2815-2820.
28. Imbert-Marcille BM, Milpied N, Coste-Burel M et al. Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients. Bone Marrow Transplant 1995; 15: 611-617.
29. Wingard JR, Chen DY-H, Burns WH et al. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 1988; 71: 1432-1437.